Watch for Dosing Confusion with Ceftolozane/Tazobactam
Reps will be promoting a new IV anti-infective, ceftolozane/tazobactam (Zerbaxa).
Ceftolozane/tazobactam is approved for complicated UTIs (cUTIs) and intra-abdominal infections (cIAIs) in adults...and higher doses are still being studied for ventilator-associated pneumonia.
Think of it as primarily covering gram-negative bacteria...including Pseudomonas and ESBL-producing Enterobacteriaceae.
Get unlimited access through an Enterprise license
Hospital Pharmacist's Letter includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 300+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Not sold to individuals